[wpml_language_selector_widget]
[wpml_language_selector_widget]
<< Back to Educational Activities
Show : Per page of 3

A Virtual Reality Experience on Targeted Treatments for Biliary Tract Cancers and Gastroesophageal Adenocarcinomas

This activity brings to life the unique mechanisms of action of bispecific antibodies, including novel, HER2-directed, biparatopic bispecific antibodies being studied for HER2-overexpressing biliary tract cancers (BTCs) and gastroesophageal adenocarcinomas (GEAs). This immersive 3D animation also reviews current and emerging treatment approaches for HER2-positive BTCs and GEAs, as well as efficacy and safety data from relevant clinical trials.

RELEASED DATE: August 02, 2024
EXPIRATION DATE: August 02, 2025

Learn More & View Event »

Gastrointestinal Cancers and HER2 Levels of Expression: Application of Biomarker Findings in Patients with Advanced Disease

Monday, November 27, 2023

6:00PM – 7:00PM ET

Please note this TeleECHO program is 6:00PM Eastern, 5:00PM Central, 4:00PM Mountain and 3:00PM Pacific.

Learn More & View Event »

Managing HER2—Positive Biliary Tract Cancers and Gastroesophageal Adenocarcinoma through Novel and Emerging Approaches in Practice

This activity helps us to explore the role of HER2-directed antibody therapy in HER2-overexpressing biliary tract cancers (BTCs) and gastroesophageal adenocarcinomas (GEAs). This program will review the mechanisms of HER2-targeted therapies and provide a visualization of treatment sequencing for BTC. In addition, participants will experience AI-generated patient management scenarios via a life-sized holographic patient display.

RELEASED DATE: March 07, 2025
EXPIRATION DATE: March 07, 2026

Learn More & View Event »
This activity is provided by Med Learning Group.
This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.
Copyright © 2025 | Med Learning Group | All Rights Reserved | Website by Divigner

Pin It on Pinterest

Scroll to Top

You are now leaving the TAILOR Site

The TAILOR Community of Care site is funded by an independent medical education grant from Jazz Pharmaceuticals. The following site is not affiliated with the TAILOR educational initiative and MLG is not responsible for its content.

I acknowledge
Go Back

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers